• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

report cover
  • 2 September 2020
  • Healthcare
  • 128 Pages
  • Report Code: 24LS-21287
  • Formate :   
Download FREE Report Sample Download PDF File

Human Vaccine -MARKET ADVISORY SERVICES

Human Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Human Vaccine market is segmented into
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine

Segment by Application, the Human Vaccine market is segmented into
Adults
Children

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Human Vaccine Market Share Analysis
Human Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Human Vaccine product introduction, recent developments, Human Vaccine sales by region, type, application and by sales channel.

The major companies include:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Human Vaccine Revenue 2015-2026
2.1.2 Global Human Vaccine Sales 2015-2026
2.2 Human Vaccine Market Size by Region: 2020 Versus 2026
2.3 Human Vaccine Sales by Region (2015-2026)
2.3.1 Global Human Vaccine Sales by Region: 2015-2020
2.3.2 Global Human Vaccine Sales Forecast by Region (2021-2026)
2.3.3 Global Human Vaccine Sales Market Share by Region (2015-2026)
2.4 Human Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Human Vaccine Revenue by Region: 2015-2020
2.4.2 Global Human Vaccine Revenue Forecast by Region (2021-2026)
2.4.3 Global Human Vaccine Revenue Market Share by Region (2015-2026)

3 Global Human Vaccine by Manufacturers
3.1 Global Top Human Vaccine Manufacturers by Sales
3.1.1 Global Human Vaccine Sales by Manufacturer (2015-2020)
3.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Human Vaccine Manufacturers by Revenue
3.2.1 Global Human Vaccine Revenue by Manufacturer (2015-2020)
3.2.2 Global Human Vaccine Revenue Share by Manufacturer (2015-2020)
3.3 Global Human Vaccine Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Human Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 CNBG
4.1.1 CNBG Corporation Information
4.1.2 CNBG Description, Business Overview
4.1.3 CNBG Human Vaccine Products Offered
4.1.4 CNBG Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.1.5 CNBG Human Vaccine Revenue by Product
4.1.6 CNBG Human Vaccine Revenue by Application
4.1.7 CNBG Human Vaccine Revenue by Geographic Area
4.1.8 CNBG Human Vaccine Revenue by Sales Channel
4.1.9 CNBG Recent Development
4.2 Changsheng Life
4.2.1 Changsheng Life Corporation Information
4.2.2 Changsheng Life Description, Business Overview
4.2.3 Changsheng Life Human Vaccine Products Offered
4.2.4 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Changsheng Life Human Vaccine Revenue by Product
4.2.6 Changsheng Life Human Vaccine Revenue by Application
4.2.7 Changsheng Life Human Vaccine Revenue by Geographic Area
4.2.8 Changsheng Life Human Vaccine Revenue by Sales Channel
4.2.9 Changsheng Life Recent Development
4.3 Zhifei
4.3.1 Zhifei Corporation Information
4.3.2 Zhifei Description, Business Overview
4.3.3 Zhifei Human Vaccine Products Offered
4.3.4 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Zhifei Human Vaccine Revenue by Product
4.3.6 Zhifei Human Vaccine Revenue by Application
4.3.7 Zhifei Human Vaccine Revenue by Geographic Area
4.3.8 Zhifei Human Vaccine Revenue by Sales Channel
4.3.9 Zhifei Recent Development
4.4 ChengDa Bio
4.4.1 ChengDa Bio Corporation Information
4.4.2 ChengDa Bio Description, Business Overview
4.4.3 ChengDa Bio Human Vaccine Products Offered
4.4.4 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.4.5 ChengDa Bio Human Vaccine Revenue by Product
4.4.6 ChengDa Bio Human Vaccine Revenue by Application
4.4.7 ChengDa Bio Human Vaccine Revenue by Geographic Area
4.4.8 ChengDa Bio Human Vaccine Revenue by Sales Channel
4.4.9 ChengDa Bio Recent Development
4.5 Kangtai
4.5.1 Kangtai Corporation Information
4.5.2 Kangtai Description, Business Overview
4.5.3 Kangtai Human Vaccine Products Offered
4.5.4 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Kangtai Human Vaccine Revenue by Product
4.5.6 Kangtai Human Vaccine Revenue by Application
4.5.7 Kangtai Human Vaccine Revenue by Geographic Area
4.5.8 Kangtai Human Vaccine Revenue by Sales Channel
4.5.9 Kangtai Recent Development
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Corporation Information
4.6.2 SINOVAC BIOTECH Description, Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Products Offered
4.6.4 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.6.5 SINOVAC BIOTECH Human Vaccine Revenue by Product
4.6.6 SINOVAC BIOTECH Human Vaccine Revenue by Application
4.6.7 SINOVAC BIOTECH Human Vaccine Revenue by Geographic Area
4.6.8 SINOVAC BIOTECH Recent Development
4.7 Hissen
4.7.1 Hissen Corporation Information
4.7.2 Hissen Description, Business Overview
4.7.3 Hissen Human Vaccine Products Offered
4.7.4 Hissen Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Hissen Human Vaccine Revenue by Product
4.7.6 Hissen Human Vaccine Revenue by Application
4.7.7 Hissen Human Vaccine Revenue by Geographic Area
4.7.8 Hissen Recent Development
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Corporation Information
4.8.2 Walvax Biotechnology Description, Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Products Offered
4.8.4 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.8.5 Walvax Biotechnology Human Vaccine Revenue by Product
4.8.6 Walvax Biotechnology Human Vaccine Revenue by Application
4.8.7 Walvax Biotechnology Human Vaccine Revenue by Geographic Area
4.8.8 Walvax Biotechnology Recent Development
4.9 GSK
4.9.1 GSK Corporation Information
4.9.2 GSK Description, Business Overview
4.9.3 GSK Human Vaccine Products Offered
4.9.4 GSK Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.9.5 GSK Human Vaccine Revenue by Product
4.9.6 GSK Human Vaccine Revenue by Application
4.9.7 GSK Human Vaccine Revenue by Geographic Area
4.9.8 GSK Recent Development
4.10 SANOFI
4.10.1 SANOFI Corporation Information
4.10.2 SANOFI Description, Business Overview
4.10.3 SANOFI Human Vaccine Products Offered
4.10.4 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.10.5 SANOFI Human Vaccine Revenue by Product
4.10.6 SANOFI Human Vaccine Revenue by Application
4.10.7 SANOFI Human Vaccine Revenue by Geographic Area
4.10.8 SANOFI Recent Development
4.11 Rong An
4.11.1 Rong An Corporation Information
4.11.2 Rong An Description, Business Overview
4.11.3 Rong An Human Vaccine Products Offered
4.11.4 Rong An Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Rong An Human Vaccine Revenue by Product
4.11.6 Rong An Human Vaccine Revenue by Application
4.11.7 Rong An Human Vaccine Revenue by Geographic Area
4.11.8 Rong An Recent Development
4.12 NuoCheng Bio
4.12.1 NuoCheng Bio Corporation Information
4.12.2 NuoCheng Bio Description, Business Overview
4.12.3 NuoCheng Bio Human Vaccine Products Offered
4.12.4 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.12.5 NuoCheng Bio Human Vaccine Revenue by Product
4.12.6 NuoCheng Bio Human Vaccine Revenue by Application
4.12.7 NuoCheng Bio Human Vaccine Revenue by Geographic Area
4.12.8 NuoCheng Bio Recent Development
4.13 Hualan Bio
4.13.1 Hualan Bio Corporation Information
4.13.2 Hualan Bio Description, Business Overview
4.13.3 Hualan Bio Human Vaccine Products Offered
4.13.4 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.13.5 Hualan Bio Human Vaccine Revenue by Product
4.13.6 Hualan Bio Human Vaccine Revenue by Application
4.13.7 Hualan Bio Human Vaccine Revenue by Geographic Area
4.13.8 Hualan Bio Recent Development
4.14 Tiantan biological
4.14.1 Tiantan biological Corporation Information
4.14.2 Tiantan biological Description, Business Overview
4.14.3 Tiantan biological Human Vaccine Products Offered
4.14.4 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Tiantan biological Human Vaccine Revenue by Product
4.14.6 Tiantan biological Human Vaccine Revenue by Application
4.14.7 Tiantan biological Human Vaccine Revenue by Geographic Area
4.14.8 Tiantan biological Recent Development
4.15 Changchun Baike
4.15.1 Changchun Baike Corporation Information
4.15.2 Changchun Baike Description, Business Overview
4.15.3 Changchun Baike Human Vaccine Products Offered
4.15.4 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.15.5 Changchun Baike Human Vaccine Revenue by Product
4.15.6 Changchun Baike Human Vaccine Revenue by Application
4.15.7 Changchun Baike Human Vaccine Revenue by Geographic Area
4.15.8 Changchun Baike Recent Development
4.16 Adimmune
4.16.1 Adimmune Corporation Information
4.16.2 Adimmune Description, Business Overview
4.16.3 Adimmune Human Vaccine Products Offered
4.16.4 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.16.5 Adimmune Human Vaccine Revenue by Product
4.16.6 Adimmune Human Vaccine Revenue by Application
4.16.7 Adimmune Human Vaccine Revenue by Geographic Area
4.16.8 Adimmune Recent Development
4.17 Zhongyianke Biotech
4.17.1 Zhongyianke Biotech Corporation Information
4.17.2 Zhongyianke Biotech Description, Business Overview
4.17.3 Zhongyianke Biotech Human Vaccine Products Offered
4.17.4 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2015-2020)
4.17.5 Zhongyianke Biotech Human Vaccine Revenue by Product
4.17.6 Zhongyianke Biotech Human Vaccine Revenue by Application
4.17.7 Zhongyianke Biotech Human Vaccine Revenue by Geographic Area
4.17.8 Zhongyianke Biotech Recent Development

5 Breakdown Data by Type
5.1 Global Human Vaccine Sales by Type (2015-2026)
5.1.1 Global Human Vaccine Sales by Type (2015-2020)
5.1.2 Global Human Vaccine Sales Forecast by Type (2021-2026)
5.1.3 Global Human Vaccine Sales Market Share by Type (2015-2026)
5.2 Global Human Vaccine Revenue Forecast by Type (2015-2026)
5.2.1 Global Human Vaccine Revenue by Type (2015-2020)
5.2.2 Global Human Vaccine Revenue Forecast by Type (2021-2026)
5.2.3 Global Human Vaccine Revenue Market Share by Type (2015-2026)
5.3 Human Vaccine Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Human Vaccine Sales by Application (2015-2026)
6.1.1 Global Human Vaccine Sales by Application (2015-2020)
6.1.2 Global Human Vaccine Sales Forecast by Application (2021-2026)
6.1.3 Global Human Vaccine Sales Market Share by Application (2015-2026)
6.2 Global Human Vaccine Revenue Forecast by Application (2015-2026)
6.2.1 Global Human Vaccine Revenue by Application (2015-2020)
6.2.2 Global Human Vaccine Revenue Forecast by Application (2021-2026)
6.2.3 Global Human Vaccine Revenue Market Share by Application (2015-2026)
6.3 Human Vaccine Average Selling Price (ASP) by Application (2015-2026)

7 North America
7.1 North America Human Vaccine Market Size YoY Growth 2015-2026
7.2 North America Human Vaccine Market Facts & Figures by Country
7.2.1 North America Human Vaccine Sales by Country (2015-2026)
7.2.2 North America Human Vaccine Revenue by Country (2015-2026)
7.3 North America Human Vaccine Sales by Type
7.4 North America Human Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccine Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Human Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Vaccine Sales by Region (2015-2026)
8.2.2 Asia-Pacific Human Vaccine Revenue by Region (2015-2026)
8.3 Asia-Pacific Human Vaccine Sales by Type
8.4 Asia-Pacific Human Vaccine Sales by Application
9 Europe
9.1 Europe Human Vaccine Market Size YoY Growth 2015-2026
9.2 Europe Human Vaccine Market Facts & Figures by Country
9.2.1 Europe Human Vaccine Sales by Country (2015-2026)
9.2.2 Europe Human Vaccine Revenue by Country (2015-2026)
9.3 Europe Human Vaccine Sales by Type
9.4 Europe Human Vaccine Sales by Application
10 Latin America
10.1 Latin America Human Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Human Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Vaccine Sales by Country (2015-2026)
10.2.2 Latin America Human Vaccine Revenue by Country (2015-2026)
10.3 Latin America Human Vaccine Sales by Type
10.4 Latin America Human Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Human Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Vaccine Sales by Country (2015-2026)
11.2.2 Middle East and Africa Human Vaccine Revenue by Country (2015-2026)
11.3 Middle East and Africa Human Vaccine Sales by Type
11.4 Middle East and Africa Human Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Human Vaccine Supply Chain Analysis
12.2 Human Vaccine Key Raw Materials and Upstream Suppliers
12.3 Human Vaccine Clients Analysis
12.4 Human Vaccine Sales Channel and Sales Model Analysis
12.4.1 Human Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Vaccine Distributors
13 Market Dynamics
13.1 Human Vaccine Market Drivers
13.2 Human Vaccine Market Opportunities
13.3 Human Vaccine Market Challenges
13.4 Human Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables

Table 1. Global Human Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 2. Major Manufacturers of Varicella

Table 3. Major Manufacturers of Influenza

Table 4. Major Manufacturers of Polio

Table 5. Major Manufacturers of Hepatitis A

Table 6. Major Manufacturers of Rabies

Table 7. Major Manufacturers of BCG

Table 8. Major Manufacturers of Hepatitis B

Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus

Table 10. Major Manufacturers of Pneumococcal

Table 11. Major Manufacturers of Rota vaccine

Table 12. Global Human Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 13. Global Human Vaccine Market Size by Region (US$ Million): 2020 VS 2026

Table 14. Global Human Vaccine Sales by Region (2015-2020) & (M Doses)

Table 15. Global Human Vaccine Sales Forecast by Region (2021-2026) & (M Doses)

Table 16. Global Human Vaccine Revenue by Region (2015-2020) & (US$ Million)

Table 17. Global Human Vaccine Revenue Forecast by Region (2021-2026) & (US$ Million)

Table 18. Global Human Vaccine Sales by Manufacturer (2015-2020) & (M Doses)

Table 19. Global Human Vaccine Sales Share by Manufacturer (2015-2020)

Table 20. Human Vaccine Revenue by Manufacturer (2015-2020) & (US$ Million)

Table 21. Human Vaccine Revenue Share by Manufacturer (2015-2020)

Table 22. Key Manufacturers Human Vaccine Price (2015-2020) & (USD/Dose)

Table 23. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2019

Table 24. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)

Table 25. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2019)

Table 26. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 27. Manufacturers Human Vaccine Product Type

Table 28. Date of International Manufacturers Enter into Human Vaccine Market

Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 30. CNBG Corporation Information

Table 31. CNBG Description and Business Overview

Table 32. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 33. CNBG Human Vaccine Product

Table 34. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 35. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 36. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 37. CNBG Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 38. CNBG Recent Development

Table 39. Changsheng Life Corporation Information

Table 40. Changsheng Life Description and Business Overview

Table 41. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 42. Changsheng Life Human Vaccine Product

Table 43. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 44. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 45. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 46. Changsheng Life Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 47. Changsheng Life Recent Development

Table 48. Zhifei Corporation Information

Table 49. Zhifei Description and Business Overview

Table 50. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 51. Zhifei Human Vaccine Product

Table 52. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 53. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 54. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 55. Zhifei Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 56. Zhifei Recent Development

Table 57. ChengDa Bio Corporation Information

Table 58. ChengDa Bio Description and Business Overview

Table 59. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 60. ChengDa Bio Human Vaccine Product

Table 61. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 62. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 63. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 64. ChengDa Bio Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 65. ChengDa Bio Recent Development

Table 66. Kangtai Corporation Information

Table 67. Kangtai Description and Business Overview

Table 68. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 69. Kangtai Human Vaccine Product

Table 70. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 71. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 72. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 73. Kangtai Human Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 74. Kangtai Recent Development

Table 75. SINOVAC BIOTECH Corporation Information

Table 76. SINOVAC BIOTECH Description and Business Overview

Table 77. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 78. SINOVAC BIOTECH Human Vaccine Product

Table 79. SINOVAC BIOTECH Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 80. SINOVAC BIOTECH Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 81. SINOVAC BIOTECH Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 82. SINOVAC BIOTECH Recent Development

Table 83. Hissen Corporation Information

Table 84. Hissen Description and Business Overview

Table 85. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 86. Hissen Human Vaccine Product

Table 87. Hissen Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 88. Hissen Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 89. Hissen Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 90. Hissen Recent Development

Table 91. Walvax Biotechnology Corporation Information

Table 92. Walvax Biotechnology Description and Business Overview

Table 93. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 94. Walvax Biotechnology Human Vaccine Product

Table 95. Walvax Biotechnology Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 96. Walvax Biotechnology Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 97. Walvax Biotechnology Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 98. Walvax Biotechnology Recent Development

Table 99. GSK Corporation Information

Table 100. GSK Description and Business Overview

Table 101. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 102. GSK Human Vaccine Product

Table 103. GSK Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 104. GSK Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 105. GSK Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 106. GSK Recent Development

Table 107. SANOFI Corporation Information

Table 108. SANOFI Description and Business Overview

Table 109. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 110. SANOFI Human Vaccine Product

Table 111. SANOFI Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 112. SANOFI Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 113. SANOFI Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 114. SANOFI Recent Development

Table 115. Rong An Corporation Information

Table 116. Rong An Description and Business Overview

Table 117. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 118. Rong An Human Vaccine Product

Table 119. Rong An Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 120. Rong An Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 121. Rong An Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 122. Rong An Recent Development

Table 123. NuoCheng Bio Corporation Information

Table 124. NuoCheng Bio Description and Business Overview

Table 125. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 126. NuoCheng Bio Human Vaccine Product

Table 127. NuoCheng Bio Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 128. NuoCheng Bio Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 129. NuoCheng Bio Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 130. NuoCheng Bio Recent Development

Table 131. Hualan Bio Corporation Information

Table 132. Hualan Bio Description and Business Overview

Table 133. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 134. Hualan Bio Human Vaccine Product

Table 135. Hualan Bio Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 136. Hualan Bio Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 137. Hualan Bio Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 138. Hualan Bio Recent Development

Table 139. Tiantan biological Corporation Information

Table 140. Tiantan biological Description and Business Overview

Table 141. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 142. Tiantan biological Human Vaccine Product

Table 143. Tiantan biological Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 144. Tiantan biological Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 145. Tiantan biological Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 146. Tiantan biological Recent Development

Table 147. Changchun Baike Corporation Information

Table 148. Changchun Baike Description and Business Overview

Table 149. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 150. Changchun Baike Human Vaccine Product

Table 151. Changchun Baike Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 152. Changchun Baike Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 153. Changchun Baike Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 154. Changchun Baike Recent Development

Table 155. Adimmune Corporation Information

Table 156. Adimmune Description and Business Overview

Table 157. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 158. Adimmune Human Vaccine Product

Table 159. Adimmune Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 160. Adimmune Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 161. Adimmune Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 162. Adimmune Recent Development

Table 163. Zhongyianke Biotech Corporation Information

Table 164. Zhongyianke Biotech Description and Business Overview

Table 165. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 166. Zhongyianke Biotech Human Vaccine Product

Table 167. Zhongyianke Biotech Human Vaccine Revenue (US$ Million) and Market Share by Product

Table 168. Zhongyianke Biotech Human Vaccine Revenue (US$ Million) and Market Share by Application

Table 169. Zhongyianke Biotech Human Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 170. Zhongyianke Biotech Recent Development

Table 171. Global Human Vaccine Sales by Type (2015-2020) & (M Doses)

Table 172. Global Human Vaccine Sales Forecast by Type (2021-2026) & (M Doses)

Table 173. Global Human Vaccine Revenue by Type (2015-2020) & (US$ Million)

Table 174. Global Human Vaccine Revenue Forecast by Type (2021-2026) & (US$ Million)

Table 175. Global Human Vaccine Sales by Application (2015-2020) & (M Doses)

Table 176. Global Human Vaccine Sales Forecast by Application (2021-2026) & (M Doses)

Table 177. Global Human Vaccine Revenue by Application (2015-2020) & (US$ Million)

Table 178. Global Human Vaccine Revenue Forecast by Application (2021-2026) & (US$ Million)

Table 179. North America Human Vaccine Sales by Country (2015-2020) & (M Doses)

Table 180. North America Human Vaccine Sales by Country (2021-2026) & (M Doses)

Table 181. North America Human Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 182. North America Human Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 183. North America Human Vaccine Sales by Type (2015-2020) & (M Doses)

Table 184. North America Human Vaccine Sales by Application (2015-2020) & (M Doses)

Table 185. Asia-Pacific Human Vaccine Sales by Region (2015-2020) & (M Doses)

Table 186. Asia-Pacific Human Vaccine Sales by Region (2021-2026) & (M Doses)

Table 187. Asia-Pacific Human Vaccine Revenue by Region (2015-2026) & (US$ Million)

Table 188. Asia-Pacific Human Vaccine Revenue by Region (2021-2026) & (US$ Million)

Table 189. Asia-Pacific Human Vaccine Sales by Type (2015-2020) & (M Doses)

Table 190. Asia-Pacific Human Vaccine Sales by Application (2015-2020) & (M Doses)

Table 191. Europe Human Vaccine Sales by Country (2015-2020) & (M Doses)

Table 192. Europe Human Vaccine Sales by Country (2021-2026) & (M Doses)

Table 193. Europe Human Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 194. Europe Human Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 195. Europe Human Vaccine Sales by Type (2015-2020) & (M Doses)

Table 196. Europe Human Vaccine Sales by Application (2015-2020) & (M Doses)

Table 197. Latin America Human Vaccine Sales by Country (2015-2020) & (M Doses)

Table 198. Latin America Human Vaccine Sales by Country (2021-2026) & (M Doses)

Table 199. Latin America Human Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 200. Latin America Human Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 201. Latin America Human Vaccine Sales by Type (2015-2020) & (M Doses)

Table 202. Latin America Human Vaccine Sales by Application (2015-2020) & (M Doses)

Table 203. Middle East and Africa Human Vaccine Sales by Country (2015-2020) & (M Doses)

Table 204. Middle East and Africa Human Vaccine Sales by Country (2021-2026) & (M Doses)

Table 205. Middle East and Africa Human Vaccine Revenue by Country (2015-2020) & (US$ Million)

Table 206. Middle East and Africa Human Vaccine Revenue by Country (2021-2026) & (US$ Million)

Table 207. Middle East and Africa Human Vaccine Sales by Type (2015-2020) & (M Doses)

Table 208. Middle East and Africa Human Vaccine Sales by Application (2015-2020) & (M Doses)

Table 209. Human Vaccine Key Raw Materials, Industry Status and Trend

Table 210. Human Vaccine Key Raw Materials and Upstream Suppliers

Table 211. Human Vaccine Clients Status and Trend

Table 212. Human Vaccine Typical Clients

Table 213. Human Vaccine Distributors

Table 214. Key Drivers: Impact Analysis (2021-2026)

Table 215. Human Vaccine Market Drivers

Table 216. Human Vaccine Market Opportunities

Table 217. Human Vaccine Market Challenges

Table 218. Human Vaccine Market Restraints

Table 219. Human Vaccine Porter?s Five Forces Analysis

Table 220. Research Programs/Design for This Report

Table 221. Key Data Information from Secondary Sources

Table 222. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Vaccine Product Picture

Figure 2. Global Human Vaccine Sales Market Share by Type in 2020 & 2026

Figure 3. Varicella Product Picture

Figure 4. Influenza Product Picture

Figure 5. Polio Product Picture

Figure 6. Hepatitis A Product Picture

Figure 7. Rabies Product Picture

Figure 8. BCG Product Picture

Figure 9. Hepatitis B Product Picture

Figure 10. Pertussis, Diphtheria, Tetanus Product Picture

Figure 11. Pneumococcal Product Picture

Figure 12. Global Human Vaccine Sales Market Share by Application in 2020 & 2026

Figure 13. Adults Examples

Figure 14. Children Examples

Figure 15. Human Vaccine Report Years Considered

Figure 16. Global Human Vaccine Market Size, (US$ Million), 2015 VS 2020 VS 2026

Figure 17. Global Human Vaccine Market Size 2015-2026 (US$ Million)

Figure 18. Global Human Vaccine Sales 2015-2026 (K Units)

Figure 19. Global Human Vaccine Market Size Market Share by Region: 2020 Versus 2026

Figure 20. Global Human Vaccine Sales Market Share Forecast by Region (2015-2026)

Figure 21. Global Human Vaccine Revenue Market Share by Region (2015-2026)

Figure 22. Global Human Vaccine Sales Share by Manufacturer in 2019

Figure 23. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 24. Global Human Vaccine Sales Market Share Forecast by Type (2015-2026)

Figure 25. Global Human Vaccine Revenue Market Share Forecast by Type (2015-2026)

Figure 26. Human Vaccine Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)

Figure 27. Global Human Vaccine Sales Market Share Forecast by Application (2015-2026)

Figure 28. Global Human Vaccine Revenue Market Share Forecast by Application (2015-2026)

Figure 29. Human Vaccine Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)

Figure 30. North America Human Vaccine Revenue 2015-2026 (US$ Million)

Figure 31. North America Human Vaccine Sales Market Share by Type (2015-2020)

Figure 32. North America Human Vaccine Sales Market Share by Application (2015-2020)

Figure 33. Asia-Pacific Human Vaccine Revenue 2015-2026 (US$ Million)

Figure 34. Asia-Pacific Human Vaccine Sales Market Share by Region (2015-2026)

Figure 35. Asia-Pacific Human Vaccine Revenue Market Share by Region (2015-2026)

Figure 36. Asia-Pacific Human Vaccine Sales Market Share by Type (2015-2020)

Figure 37. Asia-Pacific Human Vaccine Sales Market Share by Application (2015-2020)

Figure 38. Europe Human Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 39. Europe Human Vaccine Sales Market Share by Country (2015-2026)

Figure 40. Europe Human Vaccine Revenue Market Share by Country (2015-2026)

Figure 41. Europe Human Vaccine Sales Market Share by Type (2015-2020)

Figure 42. Europe Human Vaccine Sales Market Share by Application (2015-2020)

Figure 43. Latin America Human Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 44. Latin America Human Vaccine Sales Market Share by Country (2015-2026)

Figure 45. Latin America Human Vaccine Revenue Market Share by Country (2015-2020)

Figure 46. Latin America Human Vaccine Sales Market Share by Type (2015-2020)

Figure 47. Latin America Human Vaccine Sales Market Share by Application (2015-2020)

Figure 48. Middle East and Africa Human Vaccine Revenue Growth Rate 2015-2026 (US$ Million)

Figure 49. Middle East and Africa Human Vaccine Sales Market Share by Country (2015-2026)

Figure 50. Middle East and Africa Human Vaccine Revenue Market Share by Country (2015-2026)

Figure 51. Middle East and Africa Human Vaccine Sales Market Share by Type (2015-2020)

Figure 52. Middle East and Africa Human Vaccine Sales Market Share by Application (2015-2020)

Figure 53. Human Vaccine Supply Chain (Upstream and Downstream Market)

Figure 54. Global Production Market Share of Human Vaccine Raw Materials by Region in 2019

Figure 55. Human Vaccine Distribution Channels

Figure 56. Global Human Vaccine Percentage 2015-2026: Indirect Sales VS Direct Sales

Figure 57. Global Human Vaccine Percentage 2015-2026: Online Sales VS Offline Sales

Figure 58. Porter's Five Forces Analysis

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

CNBG

Changsheng Life

Zhifei

ChengDa Bio

Kangtai

SINOVAC BIOTECH

Hissen

Walvax Biotechnology

GSK

SANOFI

Rong An

NuoCheng Bio

Hualan Bio

Tiantan biological

Changchun Baike

Adimmune

Zhongyianke Biotech

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $4897

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase